Hubei Biocause Pharmaceutical Co (SZSE:000627) Dividend Payout Ratio : 0.00 (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Hubei Biocause Pharmaceutical Co Dividend Payout Ratio?

Hubei Biocause Pharmaceutical Co's dividend payout ratio for the months ended in Mar. 2024 was 0.00.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Hubei Biocause Pharmaceutical Co Ltd is 1.08, which seems too high.

The historical rank and industry rank for Hubei Biocause Pharmaceutical Co's Dividend Payout Ratio or its related term are showing as below:

SZSE:000627' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.03 Med: 0.11 Max: 1.11
Current: 1.08

During the past 13 years, the highest Dividend Payout Ratio of Hubei Biocause Pharmaceutical Co was 1.11. The lowest was 0.03. And the median was 0.11.

SZSE:000627's Dividend Payout Ratio is ranked worse than
93.94% of 297 companies
in the Insurance industry
Industry Median: 0.37 vs SZSE:000627: 1.08

As of today (2024-06-21), the Dividend Yield % of Hubei Biocause Pharmaceutical Co is 5.98%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Hubei Biocause Pharmaceutical Co was 5.98%. The lowest was 0.11%. And the median was 0.32%.

Hubei Biocause Pharmaceutical Co's Dividends per Share for the months ended in Mar. 2024 was ¥0.00.

During the past 12 months, Hubei Biocause Pharmaceutical Co's average Dividends Per Share Growth Rate was 2100.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 3.20% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -7.20% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Hubei Biocause Pharmaceutical Co was 58.70% per year. The lowest was -45.00% per year. And the median was -13.75% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Hubei Biocause Pharmaceutical Co Dividend Payout Ratio Historical Data

The historical data trend for Hubei Biocause Pharmaceutical Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Biocause Pharmaceutical Co Dividend Payout Ratio Chart

Hubei Biocause Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividend Payout Ratio

Get a 7-Day Free Trial

0.14

1.11

0.11

0.10

Hubei Biocause Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Hubei Biocause Pharmaceutical Co's Dividend Payout Ratio

For the Insurance - Life subindustry, Hubei Biocause Pharmaceutical Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hubei Biocause Pharmaceutical Co's Dividend Payout Ratio Distribution in the Insurance Industry

For the Insurance industry and Financial Services sector, Hubei Biocause Pharmaceutical Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Hubei Biocause Pharmaceutical Co's Dividend Payout Ratio falls into.

Hubei Biocause Pharmaceutical Co Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Hubei Biocause Pharmaceutical Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2023 )	/	EPS without NRI (A: Dec. 2023 )
	=	0.11	/	-0.13
	=	N/A

Hubei Biocause Pharmaceutical Co's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2024 )	/	EPS without NRI (Q: Mar. 2024 )
	=	0	/	-0.018
	=	N/A

Hubei Biocause Pharmaceutical Co (SZSE:000627) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Hubei Biocause Pharmaceutical Co Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Hubei Biocause Pharmaceutical Co's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Biocause Pharmaceutical Co (SZSE:000627) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Hubei Biocause Pharmaceutical Co Ltd (SZSE:000627) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

2nd Floor, Building 1, No. 1 Tianshan Road, Guohua Huijin Center, Zhanghe New District, Hubei Province, Jingmen, CHN, 448000

Website

http://www.tianmaogroup.net

Hubei Biocause Pharmaceutical Co Ltd is a China-based company engaged in life insurance, health insurance, accident insurance, and other life insurance businesses, medicine, and chemical businesses. The company generates its revenue in the form of premiums.

Executives

Jiang Hai Hua	Independent director
Fu Yong Jin	Directors, executives
Wu Shi Yan	Supervisors

Hubei Biocause Pharmaceutical Co (SZSE:000627) Headlines

No Headlines